Bibliographic Details
| Title: |
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease. |
| Authors: |
Peyrin-Biroulet, L.1, Chapman, J. C.2, Colombel, J.-F.3, Caprioli, F.4, D'Haens, G.5, Ferrante, M.6, Schreiber, S.7, Atreya, R.8, Danese, S.9, Lindsay, J. O.10, Bossuyt, P.11, Siegmund, B.12, Irving, P. M.13, Panaccione, R.14, Cao, Q.15, Neimark, E.16, Wallace, K.17, Anschutz, T.18, Kligys, K.18, Duan, W. R.18 |
| Source: |
New England Journal of Medicine. 7/18/2024, Vol. 391 Issue 3, p213-223. 11p. |
| Database: |
Academic Search Ultimate |
